Digital behavioral health platform NeuroFlow scores $7.5M
Builders VC led the round with participation fromDreamit Ventures, Spring Point Partners, Red & Blue Ventures and AWT Private Investments.
Related Articles
Sharp HealthCare bets big on spatial computing – Becker’s Hospital Review | Healthcare News & Analysis
“Discover how Sharp HealthCare is revolutionizing healthcare with spatial computing, blending physical and digital worlds to enhance clinician productivity and
Congress extends telehealth flexibilities: 5 notes – Becker’s Hospital Review | Healthcare News & Analysis
“Congress passes federal spending bill extending telehealth provisions through 2025, removing restrictions and expanding access to virtual care under Medicare.
Over 1 in 4 ASCs doing ‘just OK’ in 2025 – Becker’s ASC
When it comes to the state of business in 2025, over one-quarter of ASCs report doing “just OK” headed into 2025, according to a February…
The next lucrative opportunity for ASCs – Becker’s ASC
The next major growth opportunity for ambulatory ASCs may lie in partnerships with other outpatient facilities, such as urgent care clinics and orthopedic walk-in centers,…
AI nurses: Staffing solution for hospitals or a threat to quality care?
The next time you get a call about an upcoming medical appointment you may not be talking to a human
Laplace Interventional raises $22M for tricuspid valve tech
Laplace Interventional announced today that it completed a Series C financing round to support its prosthetic heart valve technology.
Hyperfine, Nvidia partner on AI-powered neuroimaging
Hyperfine (Nasdaq:HYPR) announced today that it entered into a strategic collaboration with Nvidia to leverage its AI expertise.
CoachCare acquires VitalTech
Chronic Care Management companies join forces to drive innovation in care management
Vave Health Introduces World’s First Wireless, Handheld, Whole-Body Ultrasound with a Single PZT Transducer
Vave expands its product portfolio with release of its Universal Probe, further driving its mission to bring affordable, ultra-portable imaging everywhere
Fast (< 30 min) “all-in-one” whole-body MRI for TNM staging in high-risk prostate cancer (PCa): Feasibility and comparison to 68Ga-Prostate Specific Membrane Antigen (PSMA)-PET/CT
The management of prostate cancer (PCa) relies on the optimal staging of newly diagnosed high-risk patients and recurrent disease. Multiparametric prostate magnetic resonance imaging (mpMRI)…